RESEARCHER PROFILE

Michal J. Matysiak

← Back to Medical University of Warsaw

M

Medical University of Warsaw

Acute Lymphoblastic Leukemia researchAcute Myeloid Leukemia ResearchLymphoma Diagnosis and TreatmentPlatelet Disorders and TreatmentsBlood disorders and treatments

Michal J. Matysiak works in Acute Lymphoblastic Leukemia research, Acute Myeloid Leukemia Research, Lymphoma Diagnosis and Treatment, Platelet Disorders and Treatments, Blood disorders and treatments. Recorded institutional associations include Medical University of Warsaw, Wroclaw Medical University.

360Publications
2,800Citations
22H-index

Inclusion identifies researchers whose recorded research contributions may inform their university’s understanding of its research community. It does not rank individual research quality or establish current employment.

Selected research works

Up to 100 highly cited works; DOI links open the original research. Counts reflect the collected record, not real-time citation totals.

  1. Ribosomal Protein L5 and L11 Mutations Are Associated with Cleft Palate and Abnormal Thumbs in Diamond-Blackfan Anemia Patients

    2008 · 417 citations
  2. The Genetic Landscape of Diamond-Blackfan Anemia

    2018 · 264 citations
  3. Ribosomal Protein Genes RPS10 and RPS26 Are Commonly Mutated in Diamond-Blackfan Anemia

    2010 · 259 citations
  4. Frameshift mutation in p53 regulator RPL26 is associated with multiple physical abnormalities and a specific pre-ribosomal RNA processing defect in diamond-blackfan anemia

    2012 · 152 citations
  5. Novel deletion of RPL15 identified by array-comparative genomic hybridization in Diamond–Blackfan anemia

    2013 · 107 citations
  6. Increased risk of infections and infection-related mortality in children undergoing haematopoietic stem cell transplantation compared to conventional anticancer therapy: a multicentre nationwide study

    2015 · 104 citations
  7. Clinical evaluation of moroctocog alfa (AF‐CC), a new generation of B‐domain deleted recombinant factor VIII (BDDrFVIII) for treatment of haemophilia A: demonstration of safety, efficacy, and pharmacokinetic equivalence to full‐length recombinant factor VIII

    2009 · 93 citations
  8. Pearson marrow pancreas syndrome in patients suspected to have Diamond-Blackfan anemia

    2014 · 51 citations
  9. Biallelic loss ofCDKN2Ais associated with poor response to treatment in pediatric acute lymphoblastic leukemia

    2016 · 50 citations
  10. Twenty years of Polish experience with three consecutive protocols for treatment of childhood acute myelogenous leukemia

    2005 · 39 citations
  11. Targeting the thioredoxin system as a novel strategy against B‐cell acute lymphoblastic leukemia

    2019 · 38 citations
  12. The Genetic Landscape of Diamond-Blackfan Anemia

    2019 · 38 citations
  13. Identification and characterization of acute infection with parvovirus B19 genotype 2 in immunocompromised patients in Poland

    2010 · 36 citations
  14. Predictive value of multidrug resistance proteins and cellular drug resistance in childhood relapsed acute lymphoblastic leukemia

    2007 · 35 citations
  15. COVID-19 in pediatric cancer patients is associated with treatment interruptions but not with short-term mortality: a Polish national study

    2021 · 31 citations
  16. Effect of diosgenin, a steroidal sapogenin, on the rat skeletal system.

    2016 · 29 citations
  17. Incidence, course, and outcome of Clostridium difficile infection in children with hematological malignancies or undergoing hematopoietic stem cell transplantation

    2018 · 29 citations
  18. Giant Cell Hepatitis With Autoimmune Hemolytic Anemia in Children

    2014 · 28 citations
  19. Head‐to‐head comparison of the pharmacokinetic profiles of a high‐purity factor IX concentrate (AlphaNine®) and a recombinant factor IX (BeneFIX®) in patients with severe haemophilia B

    2013 · 27 citations
  20. Diagnosis and Treatment of Iron Deficiency and Iron Deficiency Anemia in Children and Adolescents: Recommendations of the Polish Pediatric Society, the Polish Society of Pediatric Oncology and Hematology, the Polish Society of Neonatology, and the Polish Society of Family Medicine

    2024 · 23 citations
  21. A clinical study assessing the pharmacokinetics, efficacy and safety of AlphaNine®, a high-purity factor IX concentrate, in patients with severe haemophilia B

    2011 · 22 citations
  22. Results of two consecutive treatment protocols in Polish children with acute lymphoblastic leukemia

    2020 · 22 citations
  23. Prognostic significance of IKZF1 deletions and IKZF1 plus profile in children with B‐cell precursor acute lymphoblastic leukemia treated according to the ALL‐IC BFM 2009 protocol

    2022 · 21 citations
  24. Promoter methylation and expression levels of selected hematopoietic genes in pediatric B-cell acute lymphoblastic leukemia

    2015 · 20 citations
  25. Prevalence, Epidemiology, Etiology, and Sensitivity of Invasive Bacterial Infections in Pediatric Patients Undergoing Oncological Treatment: A Multicenter Nationwide Study

    2020 · 20 citations

← Return to the university profile